Maintaining Treatment
It's important to try to stay healthy so that you are more likely to be able to do the things you want to do every day. Sometimes, learning about treatments can help you understand why it's so important to stick to the plan your doctor has made for you. Try watching the videos about CF and Pulmozyme on the Pulmozyme web site. You can choose from videos like:
Your Lung Health: Why Mucus Matters
Cycle of Cystic Fibrosis Progression
How Pulmozyme Addresses Abnormal Mucus
Lung Health: Feeling Well Is Just Part of the Story
Tips for Taking Pulmozyme
If You Care for a Child Under 5
These videos make complicated ideas easier to understand, and they might just help you understand treatment.
Even if you feel good, you need to keep up with your prescribed treatment. Watch the video to hear Jeremy's story, and read the tips below for help sticking to your prescribed treatment.
This is not a substitute for a professional, medical diagnosis. You should ask your CF Care Team to explain which is the most appropriate for your treatment as approved by the Food and Drug Administration.
Here are some tips:
Rent a movie you’re excited about and do your prescribed treatments while you’re watching
Watch clips or the Webcasts online during your prescribed treatment
Work with your roommate to find a treatment schedule that works for both of you
Keep your equipment where you can see it, as a reminder
Establish a routine so you don’t forget your prescribed treatment
Indication and Usage
Daily administration of Pulmozyme® (dornase alfa) Inhalation Solution along with standard therapies is indicated in the management of cystic fibrosis patients to improve lung function. In patients with a forced vital capacity (volume of air exhaled with maximum effort and speed) greater than or equal to 40% of predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring the administration of injectable antibiotics. In our pivotal study, safety and efficacy of daily administration has not been studied in patients beyond 12 months.
Important Safety Information
Pulmozyme should not be used in patients who are allergic to any of its ingredients
Pulmozyme should be used along with standard therapies for cystic fibrosis
When starting Pulmozyme therapy, patients may experience change in or loss of their voice, discomfort in the throat, chest pain, red watery eyes, rash, dizziness, fever, or runny nose
These side effects are usually mild and short-lived
The effect of Pulmozyme on exercise tolerance has not been established in adults and children
For further information, please see the Pulmozyme full prescribing information. If you have questions, please discuss them with your CF healthcare team.
